FDA
Trump's 100% Pharma Tariff: Who Pays, Who Gets Out
Trump's 100% tariff on branded pharma imports creates a hard deadline: cut MFN pricing deals and reshore, or face full tariffs by 2030.
You've reached the end of the archive.
Want the next stories in your inbox? Subscribe to the newsletter